Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Urine Test Could Predict Outcome of Cartilage Transplant Surgery

By LabMedica International staff writers
Posted on 18 Sep 2025

Cartilage transplant surgery provides an alternative to artificial joint replacements by using donor tissue to restore knee function. More...

While many patients benefit, outcomes can vary, leaving uncertainty about who is most likely to succeed. Now, new research has revealed that urine samples contain protein biomarkers that may help predict surgical results, offering a noninvasive way to guide treatment decisions before performing any invasive procedures.

A team of researchers at the University of Missouri (Columbia, MO, USA) has been investigating biological markers to predict the outcomes of osteochondral allograft transplantation, a knee procedure that replaces damaged cartilage with healthy donor tissue. This approach preserves the patient’s natural joint rather than relying on artificial materials. The team analyzed protein biomarkers in urine, which fluctuate with age and other factors, making them dynamic indicators for surgical candidacy that can change over time.

The study identified nine proteins strongly associated with poor outcomes after surgery. Patients with elevated levels of these proteins were significantly less likely to experience success with the transplant. The findings, published in The Journal of Knee Surgery, demonstrate the potential for urine-based biomarker testing to guide patient selection and improve precision in orthopedic medicine.

This discovery could empower patients and clinicians to make more informed choices about the timing and type of knee surgery. Because biomarker levels are not fixed, patients who are not initially good candidates may later qualify, enabling flexible and personalized care. The research marks a shift from optimizing the surgery itself to optimizing the patient for surgery, laying the groundwork for more tailored orthopedic solutions.

“We’ve spent 15 years focused on optimizing the surgery for the patient, and now we are focusing on optimizing the patient for the surgery. These protein biomarkers give us important clues as to who can best benefit from this particular surgery,” said Jimi Cook, DVM ‘94, PhD ‘98, who led the research team. “By better understanding which protein biomarkers are linked with unsuccessful outcomes, we can determine the best data-driven treatment plan for each individual with knee pain before doing any invasive procedures.”

Related Links:
University of Missouri


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.